Bartholin Gland Carcinoma: Clinicopathologic Features, Including p16 Expression and Clinical Outcome

Tayyebeh Nazeran, Angela S. Cheng, Anthony Karnezis, Anna V. Tinker, C. Blake Gilks

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Bartholin gland carcinomas are rare forms of vulvar malignancy and it is unclear what proportion is associated with high-risk human papilloma virus (HPV) infection. Our hospital archives were searched for all cases of Bartholin gland carcinoma from 1984 to 2017 (n=16). We excluded 3 adenoid cystic carcinomas, which were the subject of a previous study, leaving 13 cases. We reviewed all slides and performed immunostains for p16 as a surrogate biomarker for high-risk HPV. There were 12 squamous cell carcinomas (SCCs), including 1 SCC with transitional-like morphology and 1 papillary SCC, and 1 adenocarcinoma. All SCCs showed diffuse and intense p16 expression consistent with the presence of HPV. The single case of poorly differentiated adenocarcinoma showed patchy staining. Patient age ranged from 38 to 72 yr (mean, 58.3 yr). Most tumors were low stage. All patients were treated with radical vulvectomy and inguinofemoral lymphadenectomy. Mean clinical follow-up was 53.7 mo (range, 3-181 mo), 9 patients were free of disease (75%), recurrence occurred in 3 cases, with death due to disease in 2 of the patients with recurrence, including the single patient with adenocarcinoma. All SCC of Bartholin gland expressed p16 diffusely and intensely regardless of histologic features and grade. Our results support the etiologic role of HPV in the pathogenesis of SCC of Bartholin gland. In this small study we observed SCC as the predominant histotype, and most tumors presented at early stage and were associated with relatively favorable outcomes.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalInternational Journal of Gynecological Pathology
Volume38
Issue number2
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

Fingerprint

Bartholin's Glands
Papillomaviridae
Squamous Cell Carcinoma
Carcinoma
Adenocarcinoma
Recurrence
Adenoid Cystic Carcinoma
Neoplasms
Papillary Carcinoma
Virus Diseases
Lymph Node Excision
Biomarkers
Staining and Labeling

Keywords

  • Adenocarcinoma
  • Bartholin gland carcinoma
  • Clinical outcome
  • Human papilloma virus
  • p16
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynecology

Cite this

Bartholin Gland Carcinoma : Clinicopathologic Features, Including p16 Expression and Clinical Outcome. / Nazeran, Tayyebeh; Cheng, Angela S.; Karnezis, Anthony; Tinker, Anna V.; Gilks, C. Blake.

In: International Journal of Gynecological Pathology, Vol. 38, No. 2, 01.03.2019, p. 189-195.

Research output: Contribution to journalArticle

Nazeran, Tayyebeh ; Cheng, Angela S. ; Karnezis, Anthony ; Tinker, Anna V. ; Gilks, C. Blake. / Bartholin Gland Carcinoma : Clinicopathologic Features, Including p16 Expression and Clinical Outcome. In: International Journal of Gynecological Pathology. 2019 ; Vol. 38, No. 2. pp. 189-195.
@article{74e7f78b75b84bd9b0d0fd359aa5fa0b,
title = "Bartholin Gland Carcinoma: Clinicopathologic Features, Including p16 Expression and Clinical Outcome",
abstract = "Bartholin gland carcinomas are rare forms of vulvar malignancy and it is unclear what proportion is associated with high-risk human papilloma virus (HPV) infection. Our hospital archives were searched for all cases of Bartholin gland carcinoma from 1984 to 2017 (n=16). We excluded 3 adenoid cystic carcinomas, which were the subject of a previous study, leaving 13 cases. We reviewed all slides and performed immunostains for p16 as a surrogate biomarker for high-risk HPV. There were 12 squamous cell carcinomas (SCCs), including 1 SCC with transitional-like morphology and 1 papillary SCC, and 1 adenocarcinoma. All SCCs showed diffuse and intense p16 expression consistent with the presence of HPV. The single case of poorly differentiated adenocarcinoma showed patchy staining. Patient age ranged from 38 to 72 yr (mean, 58.3 yr). Most tumors were low stage. All patients were treated with radical vulvectomy and inguinofemoral lymphadenectomy. Mean clinical follow-up was 53.7 mo (range, 3-181 mo), 9 patients were free of disease (75{\%}), recurrence occurred in 3 cases, with death due to disease in 2 of the patients with recurrence, including the single patient with adenocarcinoma. All SCC of Bartholin gland expressed p16 diffusely and intensely regardless of histologic features and grade. Our results support the etiologic role of HPV in the pathogenesis of SCC of Bartholin gland. In this small study we observed SCC as the predominant histotype, and most tumors presented at early stage and were associated with relatively favorable outcomes.",
keywords = "Adenocarcinoma, Bartholin gland carcinoma, Clinical outcome, Human papilloma virus, p16, Squamous cell carcinoma",
author = "Tayyebeh Nazeran and Cheng, {Angela S.} and Anthony Karnezis and Tinker, {Anna V.} and Gilks, {C. Blake}",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/PGP.0000000000000489",
language = "English (US)",
volume = "38",
pages = "189--195",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Bartholin Gland Carcinoma

T2 - Clinicopathologic Features, Including p16 Expression and Clinical Outcome

AU - Nazeran, Tayyebeh

AU - Cheng, Angela S.

AU - Karnezis, Anthony

AU - Tinker, Anna V.

AU - Gilks, C. Blake

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Bartholin gland carcinomas are rare forms of vulvar malignancy and it is unclear what proportion is associated with high-risk human papilloma virus (HPV) infection. Our hospital archives were searched for all cases of Bartholin gland carcinoma from 1984 to 2017 (n=16). We excluded 3 adenoid cystic carcinomas, which were the subject of a previous study, leaving 13 cases. We reviewed all slides and performed immunostains for p16 as a surrogate biomarker for high-risk HPV. There were 12 squamous cell carcinomas (SCCs), including 1 SCC with transitional-like morphology and 1 papillary SCC, and 1 adenocarcinoma. All SCCs showed diffuse and intense p16 expression consistent with the presence of HPV. The single case of poorly differentiated adenocarcinoma showed patchy staining. Patient age ranged from 38 to 72 yr (mean, 58.3 yr). Most tumors were low stage. All patients were treated with radical vulvectomy and inguinofemoral lymphadenectomy. Mean clinical follow-up was 53.7 mo (range, 3-181 mo), 9 patients were free of disease (75%), recurrence occurred in 3 cases, with death due to disease in 2 of the patients with recurrence, including the single patient with adenocarcinoma. All SCC of Bartholin gland expressed p16 diffusely and intensely regardless of histologic features and grade. Our results support the etiologic role of HPV in the pathogenesis of SCC of Bartholin gland. In this small study we observed SCC as the predominant histotype, and most tumors presented at early stage and were associated with relatively favorable outcomes.

AB - Bartholin gland carcinomas are rare forms of vulvar malignancy and it is unclear what proportion is associated with high-risk human papilloma virus (HPV) infection. Our hospital archives were searched for all cases of Bartholin gland carcinoma from 1984 to 2017 (n=16). We excluded 3 adenoid cystic carcinomas, which were the subject of a previous study, leaving 13 cases. We reviewed all slides and performed immunostains for p16 as a surrogate biomarker for high-risk HPV. There were 12 squamous cell carcinomas (SCCs), including 1 SCC with transitional-like morphology and 1 papillary SCC, and 1 adenocarcinoma. All SCCs showed diffuse and intense p16 expression consistent with the presence of HPV. The single case of poorly differentiated adenocarcinoma showed patchy staining. Patient age ranged from 38 to 72 yr (mean, 58.3 yr). Most tumors were low stage. All patients were treated with radical vulvectomy and inguinofemoral lymphadenectomy. Mean clinical follow-up was 53.7 mo (range, 3-181 mo), 9 patients were free of disease (75%), recurrence occurred in 3 cases, with death due to disease in 2 of the patients with recurrence, including the single patient with adenocarcinoma. All SCC of Bartholin gland expressed p16 diffusely and intensely regardless of histologic features and grade. Our results support the etiologic role of HPV in the pathogenesis of SCC of Bartholin gland. In this small study we observed SCC as the predominant histotype, and most tumors presented at early stage and were associated with relatively favorable outcomes.

KW - Adenocarcinoma

KW - Bartholin gland carcinoma

KW - Clinical outcome

KW - Human papilloma virus

KW - p16

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85061155237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061155237&partnerID=8YFLogxK

U2 - 10.1097/PGP.0000000000000489

DO - 10.1097/PGP.0000000000000489

M3 - Article

C2 - 29406447

AN - SCOPUS:85061155237

VL - 38

SP - 189

EP - 195

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 2

ER -